Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA101) (iFCG) Treatment for First-Line Therapy of Patients with CLL with Mutated IGHV and Without Deletion 17p
Titel:
Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA101) (iFCG) Treatment for First-Line Therapy of Patients with CLL with Mutated IGHV and Without Deletion 17p
Auteur:
Jain, Nitin Thompson, Philip Burger, Jan Borthakur, Gautam Bose, Prithviraj Estrov, Zeev Ferrajoli, Alessandra Takahashi, Koichi Garg, Naveen Wang, Xuemei Gandhi, Varsha Plunkett, William Kanagal-Shamanna, Rashmi Patel, Keyur Lopez, Wanda Kantarjian, Hagop O'Brien, Susan Keating, Michael Wierda, William